CD274 and breast carcinoma: Other studies in this regard also revealed that PD-1, PD-L1, TIM-3, LAG-3 immune checkpoints were positively associated with epithelial-mesenchymal transition (EMT) status in ESCC [36], and also tumor progress in breast cancer [37].